MY174362A - Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications - Google Patents

Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications

Info

Publication number
MY174362A
MY174362A MYPI20064567A MYPI20064567A MY174362A MY 174362 A MY174362 A MY 174362A MY PI20064567 A MYPI20064567 A MY PI20064567A MY PI20064567 A MYPI20064567 A MY PI20064567A MY 174362 A MY174362 A MY 174362A
Authority
MY
Malaysia
Prior art keywords
extract
cosmeceutical
extracts
nephelium lappaceum
radical scavenging
Prior art date
Application number
MYPI20064567A
Inventor
Devi M Palanisamy Uma
Hwee Ming Cheng
Masilamani Theanmalar
Subramaniam Thavamanithevi
Say Moi Yap
Radhakrishnan Ammu
Original Assignee
Univ Malaya
Sirim Berhad
International Medical Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaya, Sirim Berhad, International Medical Univ filed Critical Univ Malaya
Priority to MYPI20064567A priority Critical patent/MY174362A/en
Priority to PCT/MY2007/000081 priority patent/WO2008066370A1/en
Publication of MY174362A publication Critical patent/MY174362A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

There is disclosed a method of extraction of Nephelium lappaceum extracts, a composition of phenolic compounds, with high free radical scavenging activity. The extract is characterised by its radical scavenging activity with IC50 (effective concentration for 50 % inhibition) of 3.8 A?g/ml (DPPH), 1.7 A?g/ml (ABTS), 1.7 A?g/ml (Galvinoxyl), no prooxidant capabilities and a phenolic content of 762-822 mg GAE/g extract. The extract is not cytotoxic to normal mouse fibroblasts cells or splenocytes. The use of this extract alone or in combination with other active principals, is of interest to the nutraceutical, cosmeceutical and pharmaceutical industry.
MYPI20064567A 2006-11-27 2006-11-27 Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications MY174362A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI20064567A MY174362A (en) 2006-11-27 2006-11-27 Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications
PCT/MY2007/000081 WO2008066370A1 (en) 2006-11-27 2007-11-20 Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20064567A MY174362A (en) 2006-11-27 2006-11-27 Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications

Publications (1)

Publication Number Publication Date
MY174362A true MY174362A (en) 2020-04-10

Family

ID=39468101

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20064567A MY174362A (en) 2006-11-27 2006-11-27 Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications

Country Status (2)

Country Link
MY (1) MY174362A (en)
WO (1) WO2008066370A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963736B1 (en) * 2010-08-10 2012-08-31 Robert Vachy THERAPEUTIC COMPOSITION COMPRISING GALVINOXYL DERIVATIVE AND PROPOLIS AND USE THEREOF FOR LIPID CAPSID VIRUSES, IN PARTICULAR HERPES VIRUSES
FR3065876B1 (en) * 2017-05-05 2020-08-14 Basf Beauty Care Solutions France Sas USE OF A NEPHELIUM LAPPACEUM EXTRACT TO INCREASE SKIN FIRMNESS AND / OR MUCOUS
FR3069779A1 (en) * 2017-08-02 2019-02-08 Basf Beauty Care Solutions France Sas USE OF A NEPHELIUM LAPPACEUM PERICARP EXTRACT FOR MOISTURIZING SKIN AND / OR MUCOUS MEMBRANES

Also Published As

Publication number Publication date
WO2008066370A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
Ebrahimzadeh et al. Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata, B. hyrcana and C. speciosum
Alimi et al. Evaluation of antioxidant and antiulcerogenic activities of Opuntia ficus indica f. inermis flowers extract in rats
Benedı́ et al. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells
CL2011002432A1 (en) Composition comprising at least one digestive enzyme and at least one carrier, wherein the carrier comprises microcrystalline cellulose having a particle size greater than 100 um; a dosage form; the container that contains it; a process to prepare the composition; and its uses
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
WO2007112272A3 (en) Formulations of low dose diclofenac and beta-cyclodextrin
ZA200800111B (en) Pharmaceutical composition comprising simvastatin and ezetimibe
PL1933809T3 (en) Compositions for nasal delivery
WO2009077693A3 (en) Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
Kumar et al. Evaluation of anti-oxidant activities and total phenol and flavonoid content of the hydro-alcoholic extracts of Rhodiola sp.
WO2010041832A3 (en) Antioxidant active composition containing an ishige okamurae-derived compound
TW200833351A (en) New cosmetic and/or pharmaceutical compositions and their applications
MX2010001823A (en) Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11î²-hydroxysteroid dehydrogenase type-1.
WO2009157712A3 (en) Crude drug composition for cartilage regeneration, pain suppression, and edema suppression
MX353099B (en) Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent.
WO2007087623A3 (en) Methods and compositions for treating feline hyperthyroidism
WO2011051968A3 (en) Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
MY174362A (en) Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications
WO2009023664A3 (en) Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
Alam et al. Evaluation of antioxidant activity of Salix caprea flowers
WO2011150229A3 (en) Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity
WO2010079910A3 (en) Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
Park et al. Evaluation of the cosmeceutical activity of ethanol extracts from perilla frutescens var. acuta
Mathew et al. Antioxidant and antitumor activities of cultured mycelium of culinary-medicinal paddy straw mushroom Volvariella volvacea (Bull.: Fr.) singer (agaricomycetideae)